ABEO vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

ABEO

37.6
AI Score
VS
CBIO Wins

CBIO

47.9
AI Score

Investment Advisor Scores

ABEO

38score
Recommendation
AVOID NEW MONEY

CBIO

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABEO CBIO Winner
Forward P/E 18.6567 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 2745.0% 0.0% ABEO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 37.6/100 47.9/100 CBIO
Profit Margin -160.3% 0.0% CBIO
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD CBIO

Relative Price Performance (Last 90 Days)

ABEO 1M: -48.0% · 3M: -59.3% CBIO 1M: +13.4% · 3M: -19.1%

Current Technical Phase

ABEO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -17.2%), weak momentum, RSI 21

RSI (14): 21.3 · Price: $2.42

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.4 · Price: $14.15

Fundamentals Snapshot

Metric ABEO CBIO
Market Cap — —
Forward P/E -7.6 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 27.5% 0.0%
Gross Margin 0.0% 1.0%
Operating Margin -1.9% -14.3%
EPS -1.16 -7.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.